Page last updated: 2024-08-25

n-leucyldoxorubicin and Carcinoma, Non-Small Cell Lung

n-leucyldoxorubicin has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berger, DP; Breistøl, K; Fiebig, HH; Fodstad, O; Hendriks, HR; Langdon, SP1

Other Studies

1 other study(ies) available for n-leucyldoxorubicin and Carcinoma, Non-Small Cell Lung

ArticleYear
The antitumour activity of the prodrug N-L-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenografts.
    European journal of cancer (Oxford, England : 1990), 1998, Volume: 34, Issue:10

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Division; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Prodrugs; Transplantation, Heterologous

1998